How do we use biologics in rheumatoid arthritis patients with a history of malignancy?: An assessment of treatment patterns using Scandinavian registers

Katerina Chatzidionysiou; Bénédicte Delcoigne; Thomas Frisell; Merete L Hetland; Bente Glintborg; Lene Dreyer; René Cordtz; Kristian Zobbe; Dan Nordström; Nina Trokovic; Kalle Aaltonen; Sella Aarrestad Provan; Gerdur Grondal; Bjorn Gudbjornsson; Johan Askling

doi:10.1136/rmdopen-2020-001363

How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers

Katerina Chatzidionysiou, Bénédicte Delcoigne, Thomas Frisell, Merete L Hetland, Bente Glintborg, Lene Dreyer, René Cordtz, Kristian Zobbe, Dan Nordström, Nina Trokovic, Kalle Aaltonen, Sella Aarrestad Provan, Gerdur Grondal, Bjorn Gudbjornsson, Johan Askling

Department for Rheumatology and Spine Diseases

Original language	English
Journal	RMD Open
Volume	6
Issue number	2
Pages (from-to)	e001363
Number of pages	5
ISSN	2056-5933
DOIs	https://doi.org/10.1136/rmdopen-2020-001363
Publication status	Published - Sept 2020

Keywords

Arthritis
Rheumatoid
Biological Therapy
Epidemiology

Access to Document

10.1136/rmdopen-2020-001363

Cite this

Chatzidionysiou, K., Delcoigne, B., Frisell, T., Hetland, M. L., Glintborg, B., Dreyer, L., Cordtz, R., Zobbe, K., Nordström, D., Trokovic, N., Aaltonen, K., Provan, S. A., Grondal, G., Gudbjornsson, B., & Askling, J. (2020). How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers. RMD Open, 6(2), e001363. https://doi.org/10.1136/rmdopen-2020-001363

Chatzidionysiou, K, Delcoigne, B, Frisell, T, Hetland, ML , Glintborg, B, Dreyer, L, Cordtz, R, Zobbe, K, Nordström, D, Trokovic, N, Aaltonen, K, Provan, SA, Grondal, G, Gudbjornsson, B & Askling, J 2020, 'How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers', RMD Open, vol. 6, no. 2, pp. e001363. https://doi.org/10.1136/rmdopen-2020-001363

@article{71eb12175a1a49c1ae28398fd58604b4,

title = "How do we use biologics in rheumatoid arthritis patients with a history of malignancy?: An assessment of treatment patterns using Scandinavian registers",

keywords = "Arthritis, Rheumatoid, Biological Therapy, Epidemiology",

author = "Katerina Chatzidionysiou and B{\'e}n{\'e}dicte Delcoigne and Thomas Frisell and Hetland, {Merete L} and Bente Glintborg and Lene Dreyer and Ren{\'e} Cordtz and Kristian Zobbe and Dan Nordstr{\"o}m and Nina Trokovic and Kalle Aaltonen and Provan, {Sella Aarrestad} and Gerdur Grondal and Bjorn Gudbjornsson and Johan Askling",

note = "COPECARE",

year = "2020",

month = sep,

doi = "10.1136/rmdopen-2020-001363",

language = "English",

volume = "6",

pages = "e001363",

journal = "RMD Open",

issn = "2056-5933",

publisher = "BMJ Publishing Group",

number = "2",

}

TY - JOUR

T1 - How do we use biologics in rheumatoid arthritis patients with a history of malignancy?

T2 - An assessment of treatment patterns using Scandinavian registers

AU - Chatzidionysiou, Katerina

AU - Delcoigne, Bénédicte

AU - Frisell, Thomas

AU - Hetland, Merete L

AU - Glintborg, Bente

AU - Dreyer, Lene

AU - Cordtz, René

AU - Zobbe, Kristian

AU - Nordström, Dan

AU - Trokovic, Nina

AU - Aaltonen, Kalle

AU - Provan, Sella Aarrestad

AU - Grondal, Gerdur

AU - Gudbjornsson, Bjorn

AU - Askling, Johan

N1 - COPECARE

PY - 2020/9

Y1 - 2020/9

KW - Arthritis

KW - Rheumatoid

KW - Biological Therapy

KW - Epidemiology

U2 - 10.1136/rmdopen-2020-001363

DO - 10.1136/rmdopen-2020-001363

M3 - Journal article

C2 - 32900882

SN - 2056-5933

VL - 6

SP - e001363

JO - RMD Open

JF - RMD Open

IS - 2

ER -